Business
Envoy Medical adds Canadian and Hong Kong patents, total rises to 97
Envoy Medical Inc. announced the grant of a Canadian patent and a Hong Kong patent, expanding its global portfolio to 97 patents and 35 pending applications.
CitroTech Partners With Athena Intelligence on Wildfire Tech
The Colorado-based firm will integrate Athena's geospatial risk platform with its CitroSafe fire-inhibitor systems, initially targeting homes, utilities and insurers.
UBS Shares Fall as Capital Rules Weigh on Margins and Q2 Earnings Miss
UBS Group reported Q2 EPS of $0.87, below consensus, as proposed Swiss capital requirements threaten to cut earnings by up to 10%.
Roche reports strong Phase II data for diabetes drug Enicepatide
Roche's Phase II trial of Enicepatide showed HbA1c drops of up to 4.13 points and 15.5% weight loss in Type 2 diabetes patients, clearing the way for Phase III start in 2027.
Mini Cooper SE Paul Smith Edition im Test: Elektro-Kleinwagen mit Designstatement
Der vollelektrische Mini Cooper SE in einer exklusiven Kollaboration mit Sir Paul Smith vereint urbritische Fashion mit moderner E-Mobilität — ein Stadtflitzer mit Charakter.
Baselayer secures $35M Series A to verify AI agents
AI‑identity startup Baselayer raised $35 million to launch its Agentic Identity Suite, aiming to let banks and fintechs confirm the legitimacy of AI agents in transactions.
FDA approves Lantheus' BRAVNETSA for GEP-NETs
The FDA granted final approval to Lantheus Holdings' BRAVNETSA, a lutetium‑177 dotatate radioligand, deeming it bioequivalent to LUTATHERA for adult patients with somatostatin receptor‑positive gastroenteropancreatic neuroendocrine tumors.
Swvl launches 24/7 shuttle service in Madinah connecting seven hotels to holy site
The Nasdaq-listed ride-hailing operator says the round-the-clock service ties into its July partnership with Bank Albilad as it broadens beyond corporate and government clients in Saudi Arabia.
Vertex reports positive Phase 2b results for inaxaplin in kidney disease
The biotech firm said its experimental drug lowered protein markers in two small cohorts of patients with APOL1-mediated kidney disease, with no serious safety concerns.
Here Group Q4 Loss Widens as Revenue Doubles, Stock Slumps
Here Group reported Q4 revenue more than doubled to CNY 127.7 million but posted a wider net loss of CNY 169.6 million, weighed down by a CNY 124.1 million goodwill impairment tied to its Fastone acquisition.
FTI Consulting Hires Eileen Fargis as Senior Managing Director
The turnaround advisory firm adds a veteran energy and infrastructure executive to its Power, Renewables & Energy Transition practice in New York.
BBVA CEO highlights 22.2% ROTE and strong Mexico growth at BofA conference
BBVA reported a 22.2% first‑half return on tangible equity, 62% loan‑book expansion since 2021 and a surge in digital customers in Mexico, while warning of higher inflation and rates in Turkey.
Bruker Raises Full-Year Outlook on Stronger Mix, Margin Expansion
Bruker upgraded its full-year guidance at the BofA healthcare conference, citing an improving revenue mix toward higher-margin instruments and aftermarket services, and expecting at least 250 basis points of operating margin expansion in fiscal 2026.
Annexon shares drop 6.7% as biotech presents vonoprument trial data at Cantor Fitzgerald
Annexon presented phase III ARCHER II trial enrollment figures and GBS program progress at the 12th Annual Cantor Fitzgerald Global Healthcare Conference on Thursday.
Pfizer at U.S. All Stars Conference: growth shifts beyond covid
Pfizer discussed at the U.S. All Stars Conference how its growth is shifting beyond covid, according to a transcript of the remarks.
TruGolf Links Taps Polymath for Franchise Financing Options
The indoor golf franchise unit of TruGolf Holdings is developing equipment leasing and fractional ownership programs via its Polymath acquisition, expected to launch in early 2027.
NielsenIQ Announces Off-Market Takeover Bid for The U Group in Australia
NielsenIQ’s Australian subsidiary launched a conditional takeover offer for The U Group, aiming to expand its consumer data capabilities with a five-year partnership.
Generational Partners backs AI‑enabled defense and industrial hardware
General partner Van Espahbodi says AI is lowering capital barriers for hard‑tech, prompting software‑focused VCs to chase SpaceX alumni startups in defense, energy and water.
Credo raises FY2027 revenue growth outlook to 85% on optical demand
The AI connectivity company guided its optics revenue target at $600 million and projected accelerating quarterly growth toward a potential billion-dollar quarter by early FY2028.
Crane NXT Sees Nearly Doubled Addressable Market, Targets $2.5 Billion Sales Path
The security technologies company, spun off from Crane Company in 2023, outlined its post-Antares Vision acquisition strategy at the Jefferies Global Industrials Conference, projecting a long-term sales trajectory toward $2.5 billion.
Nomad Compute Appoints Brian Stockbridge as Non-Executive Director
The AQSE-listed firm brings in an experienced corporate finance veteran; outgoing director Marc Dixon departs with no reasons given.
Baldwin Insurance Shares Jump 5.4% on Report Dell's Office Eyes Acquisition
Shares of Baldwin Insurance Group rose in premarket trading after a Financial Times report said billionaire Michael Dell's family office is close to acquiring the insurance brokerage.
Beneficient Sets Q4 2026 Launch for Alternative Asset Analytics Platform
Dallas-based Beneficient plans to release AltLens, a portfolio analytics and risk tool targeting family offices and smaller institutions, in the fourth quarter of 2026.
Onex pivots to earnings story, cuts private equity exposure 19 percentage points
At Scotiabank's summit, Onex CEO Bobby Le Blanc outlined a strategic shift from NAV to earnings power, citing Convex's scale and a $1B valuation for remaining $5B in assets.
Orchestra BioMed at Wells Fargo: Partnership Model in Focus
Orchestra BioMed discusses its strategic partnerships and financial health at the Wells Fargo Healthcare Conference, highlighting its AVIM therapy and Virtue SAB products.